Literature DB >> 16465819

[Congenital malaria as a result of Plasmodium malariae in an infant born to a HIV-seropositive woman].

J Y Siriez1, L De Pontual, I Poilane, F Ledeur, D Haouchine, E Lachassine, J Lebras, J Gaudelus.   

Abstract

Congenital malaria is uncommon in France. The purpose of this report is to describe a case involving a six-week-old infant who was hospitalized with fever, hepatosplenomegaly, anemia and thrombopenia. Thick and thin blood smears were positive for Plasmodium malariae. The infant responded favorably to chloroquine. Based on this experience, we performed a search of the literature to find case reports on congenital malaria in France and compare clinical and epidemiologic data with series reported in the United States and from endemic areas. The placenta appears to provide an effective barrier against Plasmodium since infection is much more common than disease. The delay for onset of clinical symptoms is longer in temperate zones than in endemic areas. The type of parasite could account for this difference since African congenital malaria are due to Plasmodium falciparum while most cases described in the United States are due to Plasmodium vivax. We also discuss the possible implications of coinfection by HIV in the mother.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16465819

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  2 in total

1.  Congenital Plasmodium vivax malaria mimicking neonatal sepsis: a case report.

Authors:  Veronica Del Punta; Maurizio Gulletta; Alberto Matteelli; Vania Spinoni; Antonio Regazzoli; Francesco Castelli
Journal:  Malar J       Date:  2010-03-01       Impact factor: 2.979

2.  Case Report: Delayed Diagnosis of Congenital Malaria by Plasmodium vivax in a Newborn of an Eritrean Woman with Varicella Infection.

Authors:  Saba Gebremeskel Tekle; Angela Corpolongo; Alessandra D'Abramo; Maria Letizia Giancola; Marco Iannetta; Laura Scorzolini; Paola Marcozzi; Elsa Buffone; Giuseppina Liuzzi; Emanuele Nicastri
Journal:  Am J Trop Med Hyg       Date:  2018-07-12       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.